Tevogen Bio Holdings (TVGN) Convertible Debt (2023)
Tevogen Bio Holdings (TVGN) reported Convertible Debt of $14.2 million for Q4 2023.
Tevogen Bio Holdings (TVGN) Convertible Debt (2023) Analysis & Trends
Tevogen Bio Holdings has reported Convertible Debt for 1 years, with the latest figure at $14.2 million in Q4 2023.
- For the quarter ending Q4 2023, Convertible Debt changed N/A year-over-year to $14.2 million; the trailing twelve-month figure through Dec 2023 stood at $14.2 million (changed N/A YoY), and the FY2023 full-year result was $14.2 million, changed N/A from the prior year.
- Convertible Debt for Q4 2023 stood at $14.2 million.
- The five-year high for Convertible Debt was $14.2 million in Q4 2023, with the low at $14.2 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Tevogen Bio Holdings | 182.04 Mn | 181.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 14.22 Mn |